Home › Companies › MACROGENICS INC. › 2023-2024

MACROGENICS INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and MACROGENICS INC.’s Form 8-K, filed 2024-05-23 (Item 5.07 on EDGAR). Page generated 02 October 2026.

7Reported items
193Asset managers
1,460Fund votes
2024-05-21Meeting date

Proxy season: 2023-2024 2024-2025

Explore MACROGENICS INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by MACROGENICS INC.

These tallies are MACROGENICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-05-23 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

MACROGENICS INC. — official shareholder meeting results, meeting held 2024-05-21
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: Scott Jackson	45,427,543	--	--	6,045,759	4,159,809	Majority: yes
Elect Director: Margaret A. Liu, M.D.	49,514,571	--	--	2,253,648	3,864,892	Majority: yes
Elect Director: David Stump, M.D.	46,614,076	--	--	5,136,726	3,882,309	Majority: yes
Proposal 2: approved. The voting results were as follows:	53,484,470	2,134,398	14,243	--	--	Majority: yes
Proposal 3 . To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's Proxy Statement.	49,530,270	2,225,779	12,170	--	3,864,892	Majority: yes
Proposal 4 . To approve an amendment to the MacroGenics, Inc.	36,984,883	14,772,092	11,244	--	3,864,892	Majority: yes

Source: MACROGENICS INC., Form 8-K, filed with the SEC on 2024-05-23 — read the filing on EDGAR.

How asset managers voted at the MACROGENICS INC. 2023-2024 meeting

Each item below shows how the 193 asset managers that disclosed a MACROGENICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of MACROGENICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy materials.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 7 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%

FOR: 49,530,270AGAINST: 2,225,779

MACROGENICS INC.’s own tally for this item (“Proposal 3 . To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's Proxy Statement.”): 49,530,270 for, 2,225,779 against, per its Form 8-K filed 2024-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 62,560,502 outstanding shares: 79% for, 4% against (83% of the company cast a for/against vote).

The 191 asset managers below cast 96% of the shares they voted on this item FOR (48,338,621 for, 2,207,514 against).

FOR 96%

FOR: 48,338,621 (95.6%)AGAINST: 2,207,514 (4.4%)ABSTAIN: 1,336 (0.0%)NOT VOTED: 456 (0.0%)

Largest asset managers voting on “To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in t” at MACROGENICS INC., 2023-2024
Asset manager	For	Against	Vote
T. Rowe Price	8,603,130	0	For
State Street	5,791,529	0	For
Vanguard	3,666,187	0	For
RA CAPITAL MANAGEMENT, L.P.	3,353,084	0	For
Avoro Capital Advisors LLC	3,211,532	0	For
BlackRock	3,108,873	0	For
ARMISTICE CAPITAL, LLC	0	1,988,924	Against
Fidelity	1,452,745	0	For
GEODE CAPITAL MANAGEMENT, LLC	1,365,383	0	For
JPMorgan	1,307,151	0	For
Rock Springs Capital Management LP	1,305,250	0	For
Charles Schwab	1,044,998	0	For
Federated Hermes	1,004,006	3,045	For
WASATCH ADVISORS LP	989,238	0	For
WASATCH FUNDS TRUST	940,642	0	For
Northern Trust	672,276	39	For
Nuveen	615,299	0	For
TIAA	612,035	0	For
Vestal Point Capital, LP	512,119	0	For
Delaware/Macquarie	420,000	0	For
MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST	420,000	0	For
Integral Health Asset Management, LLC	417,797	0	For
Dimensional	401,466	0	For
Renaissance	379,979	0	For
PRINCIPAL GLOBAL INVESTORS	341,454	0	For

Showing the 25 largest of 191 asset managers. See all 191 in the interactive database.

2. To elect three Class II directors listed in the proxy materials to hold office until the 2027 Annual Meeting of Stockholders or until their successors are elected and qualified, or until their earlier death, resignation or removal: David Stump, M.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

90% Majority: yes · of votes cast

FOR 90%10%

FOR: 46,614,076WITHHELD: 5,136,726

MACROGENICS INC.’s own tally for this item (“Elect Director: David Stump, M.D.”): 46,614,076 for, 5,136,726 withheld, per its Form 8-K filed 2024-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 62,560,502 outstanding shares: 75% for, 8% withheld (83% of the company cast a for/withheld vote).

The 66 asset managers below cast 100% of the shares they voted on this item FOR (17,079,248 for, 0 against).

FOR 91%9%

FOR: 17,079,248 (90.8%)ABSTAIN: 1,736,841 (9.2%)

Largest asset managers voting on “To elect three Class II directors listed in the proxy materials to hold office until the 2027 Annual Meeting o” at MACROGENICS INC., 2023-2024
Asset manager	For	Abstain	Vote
T. Rowe Price	1,968,601	1,604,524	For
Vanguard	3,555,103	0	For
State Street	2,356,701	0	For
BlackRock	1,487,265	0	For
Fidelity	1,384,043	0	For
WASATCH FUNDS TRUST	940,642	0	For
TIAA	612,035	0	For
Charles Schwab	522,499	0	For
JPMorgan	506,309	0	For
Federated Hermes	501,442	0	For
Delaware/Macquarie	420,000	0	For
Direxion Shares ETF Trust	303,915	0	For
Principal	264,340	0	For
Dimensional	255,440	0	For
AIG/SunAmerica	194,993	0	For
Northern Trust	189,108	0	For
Equitable	119,638	67,030	For
Brighthouse	158,101	0	For
Victory Capital	115,085	0	For
QUANTITATIVE MASTER SERIES LLC	108,278	0	For
Lincoln Financial	84,757	0	For
John Hancock	71,643	10,051	For
SEI	70,262	0	For
ProShares	67,161	0	For
American Century	63,514	0	For

Showing the 25 largest of 66 asset managers. See all 66 in the interactive database.

3. To elect three Class II directors listed in the proxy materials to hold office until the 2027 Annual Meeting of Stockholders or until their successors are elected and qualified, or until their earlier death, resignation or removal: Margaret Liu, M.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%

FOR: 49,514,571WITHHELD: 2,253,648

MACROGENICS INC.’s own tally for this item (“Elect Director: Margaret A. Liu, M.D.”): 49,514,571 for, 2,253,648 withheld, per its Form 8-K filed 2024-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 62,560,502 outstanding shares: 79% for, 4% withheld (83% of the company cast a for/withheld vote).

The 66 asset managers below cast 100% of the shares they voted on this item FOR (18,749,059 for, 0 against).

FOR 99.6%

FOR: 18,749,059 (99.6%)ABSTAIN: 67,030 (0.4%)

Largest asset managers voting on “To elect three Class II directors listed in the proxy materials to hold office until the 2027 Annual Meeting o” at MACROGENICS INC., 2023-2024
Asset manager	For	Abstain	Vote
T. Rowe Price	3,573,125	0	For
Vanguard	3,555,103	0	For
State Street	2,356,701	0	For
BlackRock	1,487,265	0	For
Fidelity	1,384,043	0	For
WASATCH FUNDS TRUST	940,642	0	For
TIAA	612,035	0	For
Charles Schwab	522,499	0	For
JPMorgan	506,309	0	For
Federated Hermes	501,442	0	For
Delaware/Macquarie	420,000	0	For
Direxion Shares ETF Trust	303,915	0	For
Principal	264,340	0	For
Dimensional	255,440	0	For
AIG/SunAmerica	194,993	0	For
Northern Trust	189,108	0	For
Equitable	119,638	67,030	For
Brighthouse	158,101	0	For
Victory Capital	115,085	0	For
QUANTITATIVE MASTER SERIES LLC	108,278	0	For
Lincoln Financial	84,757	0	For
John Hancock	81,694	0	For
SEI	70,262	0	For
ProShares	67,161	0	For
American Century	63,514	0	For

Showing the 25 largest of 66 asset managers. See all 66 in the interactive database.

4. To elect three Class II directors listed in the proxy materials to hold office until the 2027 Annual Meeting of Stockholders or until their successors are elected and qualified, or until their earlier death, resignation or removal: Scott Jackson

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

88% Majority: yes · of votes cast

FOR 88%12%

FOR: 45,427,543WITHHELD: 6,045,759

MACROGENICS INC.’s own tally for this item (“Elect Director: Scott Jackson”): 45,427,543 for, 6,045,759 withheld, per its Form 8-K filed 2024-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 62,560,502 outstanding shares: 73% for, 10% withheld (82% of the company cast a for/withheld vote).

The 66 asset managers below cast 100% of the shares they voted on this item FOR (15,919,062 for, 0 against).

FOR 85%ABSTAIN 15%

FOR: 15,919,062 (84.6%)ABSTAIN: 2,897,027 (15.4%)

Largest asset managers voting on “To elect three Class II directors listed in the proxy materials to hold office until the 2027 Annual Meeting o” at MACROGENICS INC., 2023-2024
Asset manager	For	Abstain	Vote
T. Rowe Price	3,573,125	0	For
Vanguard	3,555,103	0	For
State Street	5,691	2,351,010	Abstain
BlackRock	1,487,265	0	For
Fidelity	1,384,043	0	For
WASATCH FUNDS TRUST	940,642	0	For
TIAA	612,035	0	For
Charles Schwab	522,499	0	For
JPMorgan	506,309	0	For
Federated Hermes	501,442	0	For
Delaware/Macquarie	0	420,000	Abstain
Direxion Shares ETF Trust	303,915	0	For
Principal	264,340	0	For
Dimensional	255,440	0	For
AIG/SunAmerica	194,993	0	For
Northern Trust	189,108	0	For
Equitable	119,638	67,030	For
Brighthouse	158,101	0	For
Victory Capital	115,085	0	For
QUANTITATIVE MASTER SERIES LLC	108,278	0	For
Lincoln Financial	33,957	50,800	Abstain
John Hancock	81,694	0	For
SEI	70,262	0	For
ProShares	67,161	0	For
American Century	63,514	0	For

Showing the 25 largest of 66 asset managers. See all 66 in the interactive database.

5. To approve the amendment to the MacroGenics, Inc. 2023 Equity Incentive Plan, as disclosed in the proxy materials.

COMPENSATIONMajority of the votes cast: yes

71% Majority: yes · of votes cast

FOR 71%AGAINST 29%

FOR: 36,984,883AGAINST: 14,772,092

MACROGENICS INC.’s own tally for this item (“Proposal 4 . To approve an amendment to the MacroGenics, Inc.”): 36,984,883 for, 14,772,092 against, per its Form 8-K filed 2024-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 62,560,502 outstanding shares: 59% for, 24% against (83% of the company cast a for/against vote).

The 66 asset managers below cast 62% of the shares they voted on this item FOR (11,732,890 for, 7,083,199 against).

FOR 62%AGAINST 38%

FOR: 11,732,890 (62.4%)AGAINST: 7,083,199 (37.6%)

Largest asset managers voting on “To approve the amendment to the MacroGenics, Inc. 2023 Equity Incentive Plan, as disclosed in the proxy materi” at MACROGENICS INC., 2023-2024
Asset manager	For	Against	Vote
T. Rowe Price	3,573,125	0	For
Vanguard	3,555,103	0	For
State Street	2,399	2,354,302	Against
BlackRock	1,487,265	0	For
Fidelity	1,317,537	66,506	For
WASATCH FUNDS TRUST	0	940,642	Against
TIAA	0	612,035	Against
Charles Schwab	522,499	0	For
JPMorgan	0	506,309	Against
Federated Hermes	501,442	0	For
Delaware/Macquarie	0	420,000	Against
Direxion Shares ETF Trust	0	303,915	Against
Principal	138	264,202	Against
Dimensional	0	255,440	Against
AIG/SunAmerica	0	194,993	Against
Northern Trust	189,108	0	For
Equitable	119,638	67,030	For
Brighthouse	0	158,101	Against
Victory Capital	0	115,085	Against
QUANTITATIVE MASTER SERIES LLC	108,278	0	For
Lincoln Financial	0	84,757	Against
John Hancock	59,404	22,290	For
SEI	70,262	0	For
ProShares	0	67,161	Against
American Century	0	63,514	Against

Showing the 25 largest of 66 asset managers. See all 66 in the interactive database.

6. To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024.

AUDIT-RELATED

99.9% fund support · no official result

FOR 99.9%

The 55 asset managers below cast 99.9% of the shares they voted on this item FOR (17,966,743 for, 376 against).

FOR: 17,966,743 (100.0%)AGAINST: 376 (0.0%)

Largest asset managers voting on “To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independe” at MACROGENICS INC., 2023-2024
Asset manager	For	Against	Vote
T. Rowe Price	3,573,125	0	For
Vanguard	3,555,103	0	For
State Street	2,356,325	376	For
BlackRock	1,487,265	0	For
Fidelity	1,384,043	0	For
WASATCH FUNDS TRUST	940,642	0	For
TIAA	612,035	0	For
Charles Schwab	522,499	0	For
Federated Hermes	501,442	0	For
Delaware/Macquarie	420,000	0	For
Direxion Shares ETF Trust	303,915	0	For
Principal	264,340	0	For
Dimensional	255,440	0	For
AIG/SunAmerica	194,993	0	For
Northern Trust	189,108	0	For
Equitable	186,668	0	For
Victory Capital	115,085	0	For
QUANTITATIVE MASTER SERIES LLC	108,278	0	For
Lincoln Financial	84,757	0	For
SEI	70,262	0	For
ProShares	67,161	0	For
American Century	63,514	0	For
WisdomTree	51,306	0	For
FRANKLIN STRATEGIC SERIES	51,100	0	For
Putnam	50,750	0	For

Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.

7. To ratify the selection by the Audit Committee of our Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024

AUDIT-RELATED

100% fund support · no official result

FOR 100%

The 12 asset managers below cast 100% of the shares they voted on this item FOR (848,970 for, 0 against).

FOR: 848,970 (100.0%)

Largest asset managers voting on “To ratify the selection by the Audit Committee of our Board of Directors of Ernst & Young LLP as the independe” at MACROGENICS INC., 2023-2024
Asset manager	For	Vote
JPMorgan	506,309	For
Brighthouse	140,459	For
John Hancock	81,694	For
ETF Series Solutions	47,524	For
Bridge Builder Trust	20,615	For
Jackson National	18,398	For
Managed Portfolio Series	11,120	For
RBC FUNDS TRUST	10,500	For
Allianz	7,314	For
GPS Funds I	2,936	For
Pacer Funds Trust	1,748	For
WILSHIRE MUTUAL FUNDS INC	353	For

Largest MACROGENICS INC. shareholders voting in 2023-2024

Ranked by the number of MACROGENICS INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 62,560,502 shares outstanding at the time of that meeting.

Top MACROGENICS INC. shareholders by shares voted, 2023-2024
#	Asset manager	% of shares outstanding
1	T. Rowe Price	13.75%
2	State Street	9.26%
3	Vanguard	5.86%
4	RA CAPITAL MANAGEMENT, L.P.	5.36%
5	Avoro Capital Advisors LLC	5.13%
6	BlackRock	4.97%
7	ARMISTICE CAPITAL, LLC	3.18%
8	Fidelity	2.32%
9	GEODE CAPITAL MANAGEMENT, LLC	2.18%
10	JPMorgan	2.09%

Reported MACROGENICS INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

MACROGENICS INC. beneficial owners on record for the 2023-2024 proxy season
Holder	% outstanding	Disclosure
BB Biotech AG	15.87%	13G
BlackRock, Inc. and affiliated persons	9.82%	DEF14A
Armistice Capital, LLC	7.31%	DEF14A
State Street	7.02%	13F
Vanguard Group	6.75%	13F
RA Capital Management, L.P.	6.48%	DEF14A
T. Rowe Price	3.90%	13F
BlackRock	2.46%	13F
Geode Capital	2.29%	13F
Scott Koenig, M.D., Ph.D.	2.08%	DEF14A

Percentages above are of 62,560,502 shares outstanding, as reported by MACROGENICS INC. on its Form 10-Q dated 2024-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from MACROGENICS INC.’s 10-Q dated 2024-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At MACROGENICS INC.'s shareholder meeting held 2024-05-21, in the 2023-2024 proxy season, 193 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,460 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of the Company's named executive officers as… — FOR was 96% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: MACROGENICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-05-23.

MACROGENICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025.